drugset / Trial / NCT02328482
Continuation Protocol to Protocol BBCO-001
RandomizedParallel-groupOpen-labelTreatment
Summary
This will be a multi-center, randomized withdrawal, open-label, non-treatment concurrent control, parallel group study. Patients completing protocol BBCO-001 will be offered the opportunity to enter into this 12-month randomized withdrawal protocol.
Timeline
- Start
- 2015-01
- Primary completion
- 2017-10
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trehalose | Small molecule | 30 g | Intravenous |